Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Cognitive rehabilitation of mildly impaired Alzheimer disease patients on cholinesterase inhibitors.

Loewenstein DA, Acevedo A, Czaja SJ, Duara R.

Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):395-402.

PMID:
15249277
[PubMed - indexed for MEDLINE]
2.

A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis.

Stuifbergen AK, Becker H, Perez F, Morison J, Kullberg V, Todd A.

Clin Rehabil. 2012 Oct;26(10):882-93. doi: 10.1177/0269215511434997. Epub 2012 Feb 2.

PMID:
22301679
[PubMed - indexed for MEDLINE]
3.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
[PubMed - indexed for MEDLINE]
4.

Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study.

Bottino CM, Carvalho IA, Alvarez AM, Avila R, Zukauskas PR, Bustamante SE, Andrade FC, Hototian SR, Saffi F, Câmargo CH.

Clin Rehabil. 2005 Dec;19(8):861-9.

PMID:
16323385
[PubMed - indexed for MEDLINE]
5.

Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease.

Olazarán J, Muñiz R, Reisberg B, Peña-Casanova J, del Ser T, Cruz-Jentoft AJ, Serrano P, Navarro E, García de la Rocha ML, Frank A, Galiano M, Fernández-Bullido Y, Serra JA, González-Salvador MT, Sevilla C.

Neurology. 2004 Dec 28;63(12):2348-53.

PMID:
15623698
[PubMed - indexed for MEDLINE]
6.

Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).

Campanozzi MD, Casali E, Neviani F, Martini E, Neri M.

Arch Gerontol Geriatr. 2007;44 Suppl 1:91-6.

PMID:
17317439
[PubMed - indexed for MEDLINE]
7.

Durability of cognitive remediation training in schizophrenia: performance on two memory tasks at 6-month and 12-month follow-up.

Fiszdon JM, Bryson GJ, Wexler BE, Bell MD.

Psychiatry Res. 2004 Jan 30;125(1):1-7.

PMID:
14967547
[PubMed - indexed for MEDLINE]
8.

A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.

Lucchi E, Minicuci N, Magnifico F, Mondini S, Calza A, Avanzi S, Villani D, Bellelli G, Trabucchi M.

Arch Gerontol Geriatr Suppl. 2004;(9):253-63.

PMID:
15207422
[PubMed - indexed for MEDLINE]
9.

Evaluating two group programmes of cognitive training in mild-to-moderate AD: is there any difference between a 'global' stimulation and a 'cognitive-specific' one?

Farina E, Mantovani F, Fioravanti R, Pignatti R, Chiavari L, Imbornone E, Olivotto F, Alberoni M, Mariani C, Nemni R.

Aging Ment Health. 2006 May;10(3):211-8.

PMID:
16777648
[PubMed - indexed for MEDLINE]
10.

Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.

Rozzini L, Costardi D, Chilovi BV, Franzoni S, Trabucchi M, Padovani A.

Int J Geriatr Psychiatry. 2007 Apr;22(4):356-60.

PMID:
17117398
[PubMed - indexed for MEDLINE]
11.

A randomized controlled trial of cognitive remediation among inpatients with persistent mental illness.

Lindenmayer JP, McGurk SR, Mueser KT, Khan A, Wance D, Hoffman L, Wolfe R, Xie H.

Psychiatr Serv. 2008 Mar;59(3):241-7. doi: 10.1176/appi.ps.59.3.241.

PMID:
18308903
[PubMed - indexed for MEDLINE]
12.

Neuropsychological rehabilitation of memory deficits and activities of daily living in patients with Alzheimer's disease: a pilot study.

Avila R, Bottino CM, Carvalho IA, Santos CB, Seral C, Miotto EC.

Braz J Med Biol Res. 2004 Nov;37(11):1721-9. Epub 2004 Oct 26.

PMID:
15517089
[PubMed - indexed for MEDLINE]
Free Article
13.

Rivastigmine in Alzheimer disease: efficacy over two years.

Grossberg G, Irwin P, Satlin A, Mesenbrink P, Spiegel R.

Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):420-31. Erratum in: Am J Geriatr Psychiatry. 2004 Nov-Dec;12(6):679.

PMID:
15249280
[PubMed - indexed for MEDLINE]
14.

Relearning face-name associations in early Alzheimer's disease.

Clare L, Wilson BA, Carter G, Roth I, Hodges JR.

Neuropsychology. 2002 Oct;16(4):538-47.

PMID:
12382992
[PubMed - indexed for MEDLINE]
15.

Occupational therapists use of cognitive interventions for clients with Alzheimer's disease.

Robert A, Gélinas I, Mazer B.

Occup Ther Int. 2010 Mar;17(1):10-9. doi: 10.1002/oti.283.

PMID:
19688778
[PubMed - indexed for MEDLINE]
16.

Cognitive strategies versus self-management skills as adjunct to vocational rehabilitation.

Vauth R, Corrigan PW, Clauss M, Dietl M, Dreher-Rudolph M, Stieglitz RD, Vater R.

Schizophr Bull. 2005 Jan;31(1):55-66. Epub 2005 Feb 16.

PMID:
15888425
[PubMed - indexed for MEDLINE]
Free Article
17.

Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.

Behl P, Bocti C, Swartz RH, Gao F, Sahlas DJ, Lanctot KL, Streiner DL, Black SE.

Arch Neurol. 2007 Feb;64(2):266-72.

PMID:
17296844
[PubMed - indexed for MEDLINE]
18.

Cognitive rehabilitation with patients having persistent, severe psychiatric disabilities.

Lewis L, Unkefer EP, O'Neal SK, Crith CJ, Fultz J.

Psychiatr Rehabil J. 2003 Spring;26(4):325-31.

PMID:
12739903
[PubMed - indexed for MEDLINE]
19.

The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.

Raskind MA, Cyrus PA, Ruzicka BB, Gulanski BI.

J Clin Psychiatry. 1999 May;60(5):318-25.

PMID:
10362441
[PubMed - indexed for MEDLINE]
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk